Today: 24 March 2026
Subscribe
Browse Category

Stock Market 8 January 2026

IDFC First Bank shares rise after savings rate cut, as Nomura flags 23% upside

IDFC First Bank shares rise after savings rate cut, as Nomura flags 23% upside

IDFC First Bank shares rose nearly 2% after the lender cut savings account interest rates by up to 200 basis points, effective Jan. 9. Nomura initiated coverage with a Buy rating and a 105-rupee target, citing expected margin recovery as deposit costs ease. The revised top savings rate drops to 6.5% from 7%. Nomura warned that profitability targets depend on deposit retention and stable credit costs.
8 January 2026
·
ANZ stock edges up as RBA warns inflation still “too high”; Feb rate call back in focus

ANZ stock edges up as RBA warns inflation still “too high”; Feb rate call back in focus

ANZ shares closed up 0.7% at A$35.68 after two days of losses, with about 4.1 million shares traded. RBA Deputy Governor Andrew Hauser said inflation above 3% remains “too high,” despite a softer November reading. Traders await quarterly CPI data on Jan. 28 and the RBA’s rate decision on Feb. 3. The S&P/ASX 200 ended 0.3% higher at 8,720.
8 January 2026
···
CBA shares stop falling — but the next CPI print could jolt Commonwealth Bank stock

CBA shares stop falling — but the next CPI print could jolt Commonwealth Bank stock

Commonwealth Bank of Australia closed up 0.03% at A$153.27 Thursday, trading about 1.0 million shares after a sharp fall the previous session. RBA Deputy Governor Andrew Hauser said inflation remains too high, keeping rate hike risks in play. Interest-rate swaps imply a 35% chance of a February hike. CBA will report half-year results and announce an interim dividend on Feb. 11.
8 January 2026
··
Lynas Rare Earths share price slips after export-curb rally as traders eye Jan. 21 update

Lynas Rare Earths share price slips after export-curb rally as traders eye Jan. 21 update

Lynas Rare Earths dropped 5.4% to A$14.24 on Thursday, reversing part of Wednesday’s 14.5% surge after China banned exports of “dual-use” items to Japan. The stock traded 8.36 million shares as investors weighed risks to rare earth supply. G7 finance ministers will meet Jan. 12 to discuss supply and a possible price floor. Lynas will report quarterly results Jan. 21.
8 January 2026
·
Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

Stock Market Today 08.01.2026

Royalty Pharma closed at $40.26, up 40% in a year, but a DCF model values shares at $179.83, about 77.6% higher. Camping World Holdings ended at $11.16, with a DCF value of $3.85, suggesting a 190% premium. Photronics traded at $31.78 after a 23.7% monthly gain; DCF analysis estimates intrinsic value at $19.02. Tanger raised $200 million in exchangeable notes and secured $550 million in term loans.
8 January 2026
···
DBS Smashes S$58, OCBC Tops S$20: Singapore Bank Stocks Hit Records as Dividend Hunt Intensifies

DBS Smashes S$58, OCBC Tops S$20: Singapore Bank Stocks Hit Records as Dividend Hunt Intensifies

DBS shares closed at a record S$58.40 after hitting S$58.80, while OCBC touched S$20.25 before easing to S$20.06, driving Singapore’s STI to another high. Dividend yields near 5% have kept buyers active despite stretched valuations. DBS is up over 30% in 12 months; OCBC has gained 19%. Analysts warn earnings pressure could test dividend payouts if credit costs rise.
8 January 2026
····
ServiceNow (NOW) stock rises as Jan. 28 earnings date set — key levels and risks to watch

ServiceNow (NOW) stock rises as Jan. 28 earnings date set — key levels and risks to watch

ServiceNow shares closed up 1.4% at $150.90 Wednesday, marking a third straight gain despite lighter-than-average trading volume. The company will report fourth-quarter and full-year 2025 results after markets close on Jan. 28. Shares remain well below their 50- and 200-day moving averages. Investors await updates on the $7.75 billion Armis acquisition and subscription revenue outlook.
8 January 2026
··
Danaher stock slips as analysts lift targets ahead of JPM Healthcare Conference, earnings

Danaher stock slips as analysts lift targets ahead of JPM Healthcare Conference, earnings

Danaher shares closed down 0.42% at $235.60 Wednesday, then edged up 0.16% after hours. CEO Rainer Blair will present at the J.P. Morgan Healthcare Conference Jan. 13, with Q4 earnings set for Jan. 28. Evercore ISI and TD Cowen raised price targets to $250 and $270, respectively. The stock traded between $233.26 and $238.00, with 2.7 million shares changing hands.
8 January 2026
··
Microsoft stock closes higher as Musk-OpenAI trial risk lands, with MSFT earnings in focus

Microsoft stock closes higher as Musk-OpenAI trial risk lands, with MSFT earnings in focus

A U.S. judge set Elon Musk’s lawsuit over OpenAI’s for-profit shift for a March jury trial, keeping Microsoft as a defendant. Microsoft shares closed up 1% at $483.47, valuing the company at about $3.85 trillion. Traders are watching Microsoft’s upcoming results for signals on Azure and AI spending. OpenAI reportedly set aside an employee stock pool worth 10% of the company, valued at $500 billion in October.
8 January 2026
···
Bristol Myers Squibb (BMY) stock jumps on UBS upgrade as investors look to January catalysts

Bristol Myers Squibb (BMY) stock jumps on UBS upgrade as investors look to January catalysts

Bristol Myers Squibb shares jumped 4.2% to $56.72 after UBS upgraded the stock to “buy” and raised its price target to $65. UBS cited upcoming catalysts but noted ongoing patent-expiry pressure through 2028. Trading volume exceeded averages as the stock outperformed peers on a down market day. Investors await the company’s Jan. 12 J.P. Morgan conference appearance and Feb. 5 quarterly results.
8 January 2026
·
1 … 599 600 601 602 603 … 1,361

Stock Market Today

  • Three Stocks Added to Zacks Strong Sell List on March 24th
    March 24, 2026, 7:00 AM EDT. Three stocks were added to the Zacks Rank #5 (Strong Sell) list on March 24th. Avanos Medical (AVNS) saw its earnings estimates cut by 31.8% in 60 days. AirSculpt Technologies (AIRS) experienced a 121.7% downward revision in earnings estimates over the same period. Amphastar Pharmaceuticals (AMPH) had its earnings outlook lowered by 23.5%. These changes reflect analysts' reduced confidence in these companies' near-term financial performance. The Zacks Rank system helps investors identify stocks likely to underperform. For those seeking gains, Zacks also highlighted seven top-ranked stocks projected for price appreciation in the next 30 days.
Go toTop